Tuesday, October 17, 2017

Author Archive

Key Upcoming FDA Catalysts May Help Rebound ADVENTRX To New Highs

Key Upcoming FDA Catalysts May Help Rebound ADVENTRX To New Highs

ADVENTRX Pharmaceuticals (AMEX:ANX) is a company that is rarely mentioned among the bigger players, though this may soon change as it gains attention heading into its 2011 product pipeline catalysts. As it enters the new year, the stock seemed poised to make new 52-week highs as it announced the much anticipated positive 12-month results for […]

Insider Selling and Options Trading May Spell Troubles for Protalix (AMEX:PLX), (NASDAQ:OREX)

Insider Selling and Options Trading May Spell Troubles for Protalix (AMEX:PLX), (NASDAQ:OREX)

Small cap biotech investments with upcoming FDA catalysts has become one of the hottest new trends, especially due to the fact that it is easy to foresee or expect catalysts based on the use of FDA calendars, and general medical timelines on drug and clinical trials. Unlike other industries where new technologies in research and […]

Osiris May Soon Become The World’s First Approved Stem Cell Therapy (NASDAQ:OSIR), (NASDAQ:IBB), (NYSE:XBI)

Osiris May Soon Become The World’s First Approved Stem Cell Therapy (NASDAQ:OSIR), (NASDAQ:IBB), (NYSE:XBI)

The stem cell market is slated to become $88.3 billion by 2014, with growth of well over 14.8% from now until then. This paves the way for potential revenues that border the imagination for any Wall Street analyst should any company become the first to see FDA approval. While at first thought this may sound […]

Three Equities Positioned To Stay Afloat During The Forthcoming Market Correction (NASDAQ:BPAX), (OTC:NEOP), (NYSE:FAZ)

Three Equities Positioned To Stay Afloat During The Forthcoming Market Correction (NASDAQ:BPAX), (OTC:NEOP), (NYSE:FAZ)

Ever since The New York Stock Exchange building opened on April 22, 1903, it has flawlessly followed a particular pattern that, even to this day, still stands: hope, greed, skepticism, followed by, fear, panic, despondency whereby the pattern is once again repeated by beginning with hope. It is a cycle that can either make or […]

Two Biotech Companies Poised For Gains As Call Options Boost Investor Sentiment (NASDAQ:CLDA), (NASDAQ:BPAX)

Two Biotech Companies Poised For Gains As Call Options Boost Investor Sentiment (NASDAQ:CLDA), (NASDAQ:BPAX)

In a day and age where uncertainty seems to rule the culture of the stock market world, call and put options have become increasingly popular in order to hedge a portfolio from a potential unforeseen event. Unfortunately, this is how most investors view options, however, many forget that it could also be used as a […]

Neoprobe Looks To Become A Major Player In The Oncology Market (OTC:NEOP), (NASDAQ:IBB), (NYSE:XBI), (NASDAQ:DEPO), (NASDAQ:AMRN), (NASDAQ:CORT)

Neoprobe Looks To Become A Major Player In The Oncology Market (OTC:NEOP), (NASDAQ:IBB), (NYSE:XBI), (NASDAQ:DEPO), (NASDAQ:AMRN), (NASDAQ:CORT)

Within the $40 trillion dollar US market, the biotechnology sector has become a hot investment option for those looking to hedge against a possible upcoming market correction. During the past six months, shares within the NASDAQ Bio Index (NASDAQ:IBB) are up 20.12%, while the S&P Bio Index (NYSE:XBI) matched those gains with 21.02%. This is […]

BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011 (NASDAQ:BPAX), (NASDAQ:ETRM), (AMEX:LCI), (AMEX:YMI)

BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011 (NASDAQ:BPAX), (NASDAQ:ETRM), (AMEX:LCI), (AMEX:YMI)

Following the Christmas break, shares of BioSante (NASDAQ:BPAX) soared more than 27% during Monday’s session on volume of 10.57M shares versus an average of 251,478, leaving investors hungry for the company’s potential in its upcoming FDA catalysts in early 2011, as highlighted by our previous article. All seemed well going into the next trading session, […]

Options and Analyst Estimates Paint a Rosy Future for Clinical Data (CLDA, PFE, LLY, FRX, GSK, MRK)

Options and Analyst Estimates Paint a Rosy Future for Clinical Data (CLDA, PFE, LLY, FRX, GSK, MRK)

This once small and unnoticed biotechnology company has now turned into the talk of the town, having everyone awaiting anxiously for its blockbuster drug, Vilazodone, to receive word from the FDA on approval during the set January, 22, 2011 action date. With game-changing potential to completely revolutionize the annual $12 billion dollar antidepressant market, it […]

Irish Bailout Was Simply A Shifting Of Creditors (IRE, EWP, NBG, PT)

Irish Bailout Was Simply A Shifting Of Creditors (IRE, EWP, NBG, PT)

Many different parties celebrated the recent $113B bailout of Ireland (NYSE:IRE), especially given that Greece (NYSE:NBG) is doing so well now (note the sarcasm). Oh, but the fun doesn’t stop there for taxpayers, no, no,, in fact you can expect Spain (NYSE:EWP) and Portugal (NYSE:PT) to follow suit, leading to a complete collapse of the […]

US Dollar Surging as Mainstream Media Claims the Opposite (UUP, UDN)

US Dollar Surging as Mainstream Media Claims the Opposite (UUP, UDN)

The US Dollar (NYSE:UUP) and (NYSE:UDN) has received nothing short of negative press since the introduction of Quantitative Easing part deux, amassing a total of $600 billion in printed paper (none of which is backed by gold bouillon). In theory, all exogenous variables equal, this event should depreciate the currency, however, it has done the […]

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo